Aytu BioPharma Inc (LTS:0A8M)
$ 1.59 -0.01 (-0.62%) Market Cap: 9.90 Mil Enterprise Value: 6.35 Mil PE Ratio: 0 PB Ratio: 0.33 GF Score: 40/100

Q4 2024 Aytu Biopharma Inc Earnings Call Transcript

Sep 26, 2024 / 08:30PM GMT
Release Date Price: $2.5 (+0.40%)
Operator

Greetings. Welcome to the Aytu Biopharma fiscal 2024 Q4 earnings call. (Operator Instructions) Please note this conference is being recorded.

I will now turn the conference over to your host, Robert Blum with Lytham Partners. You may begin.

Robert Blum
Lytham Partners - Moderator

All right. Thank you very much. Good afternoon, everyone, and thank you for joining us for as the operator indicated Aytu Biopharma's fiscal 2024 full year and fourth quarter operational and financial results conference call for the period ended June 30, 2024. Joining us on today's call is Aytu's Chief Executive Officer, Josh Disbrow; and the company's Chief Financial Officer, Mark Oki.

At the conclusion of today's prepared remarks, we will open the call for a question and answer session. I'd like to remind everyone that today's call is being recorded. A replay of today's call will be available by using the telephone numbers and conference ID provided in the press release issued earlier today or by utilizing the link on the company's website under Events and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot